Alzheimer Demenz / Alzheimer dementia
Vom Modell zum Wirkstoff / from model to drug
News
Zurück zur Übersicht
15.11.2021
Discovery of a novel pseudo β-hairpin structure of N-truncated amyloid-β for use as a vaccine against Alzheimer’s disease
LifeArc scientists, in collaboration with researchers in the UK and University Medical Centre Göttingen, have developed a promising new approach to potentially treat Alzheimer’s disease – and also vaccinate against it. Both the antibody-based treatment and the protein-based vaccine developed by the team reduced Alzheimer’s symptoms in mouse models of the disease. The research is published today in Molecular Psychiatry.
Zurück zur Übersicht